All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Reduction of paediatric emergence agitation after adenotonsillectomy with nalbuphine

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F17%3A00067377" target="_blank" >RIV/65269705:_____/17:00067377 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/17:00098198

  • Result on the web

    <a href="http://www.alliedacademies.org/articles/reduction-of-paediatric-emergence-agitation-after-adenotonsillectomywith-nalbuphine-7932.html" target="_blank" >http://www.alliedacademies.org/articles/reduction-of-paediatric-emergence-agitation-after-adenotonsillectomywith-nalbuphine-7932.html</a>

  • DOI - Digital Object Identifier

    —

Alternative languages

  • Result language

    angličtina

  • Original language name

    Reduction of paediatric emergence agitation after adenotonsillectomy with nalbuphine

  • Original language description

    Abstract Background and aim: The aim of this prospective, observational study was to evaluate the potential benefit of nalbuphine in paediatric adenotonsillectomy in comparison to alfentanil in the terms of the emergence delirium and other procedural adverse events. Methods: Monitored adverse events were tachycardia, dyspnoea, hypotension, hypertension and emergence agitation according to the adapted Watcha scale. All eligible patients were given oral premedication and general anaesthesia was induced using inhalational or intravenous route. Patients were given nalbuphine (0.1-0.2 mg.kg-1) or alfentanil (10-15 ug.kg-1) and had all requested data recorded in the study form (age, study group, metamizole usage, body weight, total dose of nalbuphine or alfentanil, ASA, studied parameters). Results: Total of 122 patients were enrolled for this study, 8 patients were excluded because of incomplete study form. This resulted in study population of 114 patients. All patients were ASA I-II. No differences in age or body weight were observed. Emergence agitation was significantly (p=0.024) more frequent in the Alfentanil group (39.66%) than in Nalbuphine group (19.64%). Tachycardia was significantly more frequent in younger patients. Dyspnoea was significantly dose-dependent and more frequent in lower dosages (p=0.045). Hypertension was more frequent in patients with higher grade of agitation, but statistically significant only in the Alfentanil group (p=0.044). Conclusion: Nalbuphine in the setting of paediatric adenotonsillectomy makes a good alternative to short acting opioid and postoperative analgesia using NSAID or other nonopioid analgesics. Our results show that nalbuphine provides less emergence agitation and therefore provides a patient better early postoperative outcome.

  • Czech name

    —

  • Czech description

    —

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

    —

  • OECD FORD branch

    30209 - Paediatrics

Result continuities

  • Project

    —

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Current Pediatric Research

  • ISSN

    0971-9032

  • e-ISSN

    —

  • Volume of the periodical

    21

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    IN - INDIA

  • Number of pages

    7

  • Pages from-to

    490-496

  • UT code for WoS article

    —

  • EID of the result in the Scopus database

    2-s2.0-85028559348